Case Western Reserve University
Paul Litman is a research assistant in Dr. Rebecca Darrah's lab at Case Western Reserve University in Cleveland, Ohio. Paul’s research has been primarily focused on pulmonary manifestations in CF and on modifiers of CF disease outcomes. Most recently, he has been working to determine potential outcomes attributed to the use of Highly Effective Modulator Therapy (HEMT, ETIs) during pregnancy in CF mouse models.
W17.1- Neurological outcomes of in-utero treatment with ETI
Friday, October 24, 2025
7:45 AM - 9:45 AM PDT